1. Home
  2. INVE vs ONCY Comparison

INVE vs ONCY Comparison

Compare INVE & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Identiv Inc.

INVE

Identiv Inc.

HOLD

Current Price

$2.60

Market Cap

115.7M

Sector

Technology

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.94

Market Cap

98.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INVE
ONCY
Founded
1990
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Computer peripheral equipment
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
115.7M
98.7M
IPO Year
1997
2002

Fundamental Metrics

Financial Performance
Metric
INVE
ONCY
Price
$2.60
$0.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$5.50
$7.33
AVG Volume (30 Days)
131.8K
1.7M
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$60,219,000.00
N/A
Revenue This Year
$22.10
N/A
Revenue Next Year
$20.74
$2,505.00
P/E Ratio
N/A
N/A
Revenue Growth
7.21
N/A
52 Week Low
$2.43
$0.71
52 Week High
$5.30
$1.51

Technical Indicators

Market Signals
Indicator
INVE
ONCY
Relative Strength Index (RSI) 22.40 56.21
Support Level N/A $0.90
Resistance Level $3.75 $1.18
Average True Range (ATR) 0.17 0.06
MACD -0.13 0.01
Stochastic Oscillator 10.18 72.78

Price Performance

Historical Comparison
INVE
ONCY

About INVE Identiv Inc.

Identiv Inc develops specialty radio-frequency identification (RFID) and Internet of Things It (IoT) solutions that address customers' challenges and create new opportunities for them through the digitization and enhanced connectivity to the IoT. It designs, produces, and sells RFID and Bluetooth Low Energy (BLE) enabled devices, RFID inlays, tags, and labels that can be applied or incorporated into physical objects, providing them with a digital identity and the ability for customers to track, monitor, authenticate, and engage with consumers. Its IoT Business segment develops, manufactures, and supplies specialty IoT solutions tailored for the healthcare, logistics, smart packaging industries and other high-value end markets.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: